Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapyAnne Vincent-Salomon, Alexandra Rousseau, Michel Jouve, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2007
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery firstMarc A Bollet, Brigitte Sigal-Zafrani, Valérie Mazeau, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 2005
KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcomeSandy Azoulay, Marick Laé, Paul Fréneaux, et al.International Journal of Cancer|June 12, 2013
Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomasNicolas Pécuchet, Tatiana Popova, Elodie Manié, et al.Plos One|April 25, 2012
Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinomaFabien Reyal, Marc A Bollet, Martial Caly, et al.Breast Cancer Research : BCR|July 30, 2009
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatmentMarc A Bollet, Alexia Savignoni, Leanne De Koning, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breastAnne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, et al.Anticancer Research|May 16, 2009
Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patientsPatricia De Cremoux, Laure Grandin, Véronique Diéras, et al.Journal of the National Cancer Institute|December 27, 2007
High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancersMarc A Bollet, Nicolas Servant, Pierre Neuvial, et al.Cancer Research|May 16, 2015
Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease SubtypesCristina Ghirelli, Fabien Reyal, Marine Jeanmougin, et al.Pageof 8